Pharming Group NV
AEX:PHARM
Pharming Group NV
AEX:PHARM
Price:
1.405
EUR
-0.35%
Market Cap:
€962.6m
Wall Street
Price Targets
PHARM Price Targets Summary
Pharming Group NV
Pharming Group NV
Wall Street analysts forecast PHARM stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
PHARM
is 2.193 EUR
with a low forecast of 1.818 EUR and a high forecast of 2.73 EUR.
Lowest
Price Target
1.818
EUR
29% Upside
Average
Price Target
2.193
EUR
56% Upside
Highest
Price Target
2.73
EUR
94% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PHARM's stock price target?
Price Target
2.193
EUR
2.193
EUR
According to Wall Street analysts, the average 1-year price target for
PHARM
is 2.193 EUR
with a low forecast of 1.818 EUR and a high forecast of 2.73 EUR.
What is Pharming Group NV's Revenue forecast?
Projected CAGR
8%
8%
For the last 13 years the
compound annual growth rate for
Pharming Group NV's revenue is
42%.
The projected
CAGR
for the next 4 years is
8%.
